View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AT87 | Publication ID: Fall 2018 |
Title: ●Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency (CMS-4187-P) | |
Abstract:
This proposed rule would revise the Federal Health Insurance Programs for the Aged and Disabled by amending the Medicare Parts A, B, C and D programs, as well as the Medicaid program, to require drug pricing transparency. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Undetermined | Unfunded Mandates: Undetermined |
EO 13771 Designation: Regulatory | |
CFR Citation: 42 CFR 403 | |
Legal Authority: 42 U.S.C. 1302 42 U.S.C. 1395hh |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: Undetermined |
Federalism: Undetermined | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Cheri Rice Deputy Director, Center for Medicare, Parts C & D Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare, MS: C1-13-07, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-3000 |